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Abstract 
The JAR human placental choriocarcinoma cells were found to transport camitine into the intracellular space by a Na+-dependent 
process. The transport showed no requirement for anions. The Na+-dependent process was saturable and the apparent Michaelis-Menten 
constant for carnitine was 12.3 + 0.5 pLM. Na + activated the transport by increasing the affinity of the transport system for camitine. The 
transport system specifically interacted with L-carnitine, D-carnitine, acetyl-DL-camitine and betaine. 6-N-Trimethyllysine and choline had 
little or no effect on carnitine transport. Of the total transport measured, transport into the intracellular space represented 90%. Plasma 
membrane vesicles prepared from JAR cells were found to bind camitine in a Na+-dependent manner. The binding was saturable with an 
apparent dissociation constant of 0.66 + 0.08 o~M. The binding process was specific for L-carnitine, D-carnitine, acetyl-DL-camitine, and 
betaine. 6-N-Trimethyllysine and choline showed little or no affinity. It is concluded that the JAR cells express a Na+-dependent 
high-affinity system for carnitine transport and that the Na+-dependent high-affinity camitine binding detected in purified JAR cell 
plasma membrane vesicles is possibly related to the transmembrane transport process. 
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1. Introduction brane vesicles have demonstrated Na+-dependent, high-af- 
finity, carnitine binding in this membrane [7]. The brush- 
Despite the very low ability for biosynthesis of carnitine border membrane of the placental syncytiotrophoblast faces 
in developing fetuses [1-4], camitine levels in fetal circu- the maternal side and is in direct contact with maternal 
lation are significantly higher than in maternal circulation blood. We speculated that the Na+-dependent camitine 
[5,6]. These observations strongly suggest hat the placenta binding identified in this membrane is involved in the 
is capable of active transfer of carnitine from mother to active transport of carnitine from maternal blood into the 
fetus. Carnitine is an obligate requirement for fatty acid syncytiotrophoblast [7],
oxidation. The process of carnitine transport across the To gain a better understanding of the placental transport 
placenta is of physiological importance because this en- of carnitine and of the relevance of the Na+-dependent 
ables the fetus to build up tissue reserves of carnitine in carnitine binding in the placental brush-border membrane 
preparation for metabolic transition which occurs at birth, to the transport process, we investigated carnitine transport 
While glucose is the major source of energy during prena- in choriocarcinoma cells (JAR) derived from human pla- 
tal development, fatty acids become the primary metabolic centa. The JAR cells have been extensively used in our 
fuel during the immediate postnatal period. Very little is laboratory as a model to study placental transport of 
known on the cellular mechanism involved in the transfer several organic solutes including amino acids [8-11], 
of carnitine across the placenta from mother to fetus. Our monoamines [12], vitamins [13], and thyroid hormones 
studies with purified human placental brush-border mere- [14]. The results of the current investigation reveal that 
these cells possess a Na+-dependent active mechanism for 
camitine transport and that the Na+-dependent binding 
observed in the plasma membrane is related to the trans- 
* Corresponding author. Fax: + 1 706 7216608. port process. 
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2. Materials and methods 2.4. Differentiation between transport and binding in cells 
2.1. Materials The cells were incubated with [3H]carnitine for 60 min. 
Total carnitine associated with the cells which represented 
binding plus transport was determined as described above. 
L-[methyl-3H]Carnitine (specific radioactivity, 77 To determine the relative contribution of binding versus 
Ci/mmol) was purchased from Amersham. 5-[1,2-3H]Hy - transport o the total carnitine associated with cells, the 
droxytryptamine (serotonin) (specific radioactivity, 30.4 cells were lysed with 1 ml of 5 mM Tris-HC1 buffer, pH 
Ci/mmol) was purchased from Du Pont-New England 7.5, and the lysate was subjected to centrifugation at 
Nuclear. L-Carnitine, D-carnitine, acetyl-DL-carnitine, 6-N- 100000 × g for 1 h. The radioactivity associated with the 
trimethyllysine, [3-hydroxybutyrate, ",/-aminobutyrate, be- pellet and with the supernatant was then determined. 
taine, choline and N-methylglucamine w re obtained from 
Sigma. All other chemicals were of analytical grade. 
The JAR human placental choriocarcinoma cells were 2.5. Preparation of plasma membrane vesicles .from cul- 
purchased from the American Type Culture Collection tured JAR cells 
(Rockville, MD, USA). RPMI 1640 culture medium, peni- 
cillin, and streptomycin were obtained from Life Tech- 
nologies. Fetal bovine serum was from Sigma. The cells were cultured in 225-cm 2 flasks and plasma 
membrane vesicles were prepared from the cells as de- 
scribed previously [15]. Briefly, the culture medium was 
2.2. Culture of JAR cells removed by aspiration. The cells were chilled on ice and 
washed with 10 ml of ice-cold phosphate-buffered saline, 
The cells were cultured with RPMI 1640 medium as and lysed with 25 ml of ice-cold 10 mM Tris/HC1 buffer, 
described previously [8]. The medium was supplemented pH 7.5, containing 2 mM EGTA. The lysate was homoge- 
with 10% fetal bovine serum, 100 units/ml penicillin, and nized for 30 s in an Ultra-Turrax. A stock solution of 1 M 
100 p~g/ml streptomycin. Trypsin-released cells were MgC12 was added to the homogenate ogive a final MgC12 
seeded in 35-mm Petri dishes at a density of 1.5. 10 6 concentration of 10 raM. The mixture was stirred at 4°C 
cells/dish and allowed to grow as a monolayer. 24 h after for 10 min and centrifuged at 3000 × g for 15 rain. The 
subculturing, the medium was replaced with fresh culture resulting supernatant was again centrifuged at 60000 X g 
medium, and the cells were used for uptake measurements for 30 min and the pellet containing plasma membranes 
the following day. was rinsed with and suspended in 20 mM Hepes/Tris 
buffer, pH 7.5, containing 150 mM mannitol and 75 mM 
potassium gluconate. These membrane preparations were 
2.3. Transport measurements found to be enriched in alkaline phosphatase activity 
(marker for plasma membrane) 8 to 10-fold compared to 
the homogenate. All steps involved in transport measurements were car- 
ried out at room temperature. The medium was aspirated, 
and the cells were washed once with the transport buffer. 1 
2.6. Transport~binding measurements in membrane uesi- ml of transport buffer containing [3H]carnitine was added 
cles to the cells and incubated for the desired time. Transport 
was terminated by aspirating the buffer and subsequently 
washing the cells three times with fresh uptake buffer. The Transport/binding was initiated by mixing 40 txl of 
cells were lysed with 1 ml of 0.2 N NaOH-I% SDS, and membrane vesicles with 160 Ixl of transport/binding 
the lysate was transferred to scintillation vials for quantita- medium containing radiolabeled substrate (carnitine or 
tion of radioactivity. The composition of the transport serotonin). The composition of the transport/binding 
buffer in most experiments was 25 mM Hepes/Tris, pH medium was 20 mM Hepes/Tris, pH 7.5 and 150 mM 
7.5, 140 mM NaC1, 5.4 mM KC1, 1.8 mM CaC12, 0.8 mM NaC1 or KC1. The mixture was incubated at room tempera- 
MgSO 4, and 5 mM glucose. In experiments dealing with ture for the desired time. At the end of incubation, trans- 
the anion dependence of carnitine transport, he composi- port/binding was terminated by the addition of 3 ml of 
tion of the transport buffer was modified by substituting ice-cold 5 mM Hepes/Tris buffer, pH 7.5, containing 160 
potassium gluconate for KC1 and calcium gluconate for mM KC1, followed by filtration under vacuum on a Milli- 
CaC12 and sodium salts containing the desired anion for pore Filter (DAWP type, 0.65 txm pore size). The filter, 
NaC1. In experiments dealing with the influence of Na + on which retained the plasma membrane vesicles, was washed 
carnitine transport, he buffers containing 140 mM NaCI or four times with 5 ml of the same KCl-buffer, following 
140 mM N-methylglucamine chloride were mixed to give which the radioactivity associated with the filter was deter- 
uptake buffers of desired Na + composition, mined by liquid scintillation spectrometry. 
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2. 7. Statistics Table 1 
Influence of monovalent cations and anions on carnitine transport in JAR 
Experiments were routinely made in duplicate or tripli- placental choriocarcinoma cells 
cate and each experiment was repeated two to three times. Salt Carnitine transport 
The results are given as means +_ S.E. Kinetic analyses 5 nM( fmol /mg 10 txM(pmol/mg 
were done using a commercially available computer pro- per 10 mini per l0 mini 
gram Fig. P. version 6.0 (BioSoft, Cambridge, United NaG1 43.5+0.5(100) 41.5+0.1 (100) 
Kingdom). Na gluconate 49.9 + 0.6 (115) 44.3 + 0.1 (107) 
NaNO 3 33.7 +0.3 (78) ND 
NaI 30.7 +0.6 (71) ND 
NaF 66.6+ 1.6 (153) 47.7_+0.6 (115) 
3. Resu l t s  NaSCN 24.0+0.1 (55) 30.0-+0.2 (72) 
LiC1 24.7 -+ 0.2 (57) 25.8 -+ 0.3 (62) 
3.1. Time course o f  carnit ine transport  KCI 5.0-+ 0.1 (12) 13.3 _+ 0.2 (32) 
Choline CI 2.2 _+ 0.3 (5) 5.4 + 0.2 (13) 
Fig. 1 describes the time course of carnitine transport in Transport of carnitine (5 nM or 10 IxM) in monolayer cultures of JAR 
JAR human placental choriocarcinoma cells in the pres- cells was measured with a 10 min incubation in the presence of 140 mM 
ence of either choline chloride or NaG1 in the extracellular of indicated inorganic salts in the extracellular medium. Values are 
medium. There was very little transport from the medium means _+ S.E. Values in parentheses are percent of respective control 
containing choline chloride. The presence of NaCI in the transport measured in the presence of NaCI. ND, not determined. 
medium stimulated the transport several-fold. The NaC1- 
dependent transport was linear at least up to 60 rain. effect on the transport. Similarly, when C1- was replaced 
with NO 3 and I-, the effect was minimal. F-  stimulated 
3.2. Dependence of carnitine transport on cations and the transport and SCN- reduced the transport to a signifi- 
anions cant extent. The data however show that C1- is not 
obligatory for carnitine transport. Thus, the transport of 
The role of different monovalent cations and anions in camitine in JAR cells is a Na+-dependent process with no 
the transport of carnitine (5 nM or 10 IxM) in JAR cells dependence on C1-. 
was then investigated (Table 1). Replacement of NaC1 with 
KCI or choline chloride drastically reduced the transport, 3.3. Substrate specificity of the JAR cell carnitine trans- 
showing that Na + is obligatory for the transport process, port system 
There was however substantial transport of carnitine when 
LiC1 replaced NaCI in the medium, suggesting that Li + The influence of various structurally related compounds 
can substitute for Na + to a significant extent. The anion (500 p~M) on the transport of [3H]camitine (3 nM or 10 
influence on the transport was studied by measuring the IxM) was studied to determine the substrate specificity of 
transport in the presence of sodium salts containing differ- the system that is responsible for the transport of camitine 
ent anions. Substitution of C1- with gluconate had no in JAR cells (Table 2). The transport was inhibited 
400 Table 2 
Substrate specificity of the carnitine transport system in JAR placental 
choriocarcinoma cells 
"2 300 Substrate [3H]Carnitine transport 
o. ~ Analog 3 nM (fmol/mg 10 ~M (pmol/mg 
~ per 30 mini per 30 mini 
f f  200 None 72.8+2.6(100) 129.4+1.9(100) 
L-Carnitine 3.1 + 0.1 (4) 7.3 + 0.1 (6) - .~  "~.  - -  _ 
-~. "~ D-Camitine 9.5+0.2 (13) 40.9+0.3 (32) 
~ Acetyl-DL-carnitine 9.1 +0.3 (13) 30.4___0.2 (24) 
¢D w 100 Betaine 29.1+ 1.3 (40) 85.2+2.1 (66) 
6-N-Trimethyllysine 67.0 _ 1.4 (92) ND 
[3-Hydroxybutyrate 71.2 + 2.3 (98) ND 
: ~ i m ",/-Aminobutyrate 71.2_ 1.8 (98) ND 
15 30 45 60 Choline 71.0 + 1.8 (98) 127.5 + 2.2 (99) 
Time (mini Transport of [3H]camitine (3 nM or 10 p~M) in monolayer cultures of 
Fig. 1. Time course of carnitine transport in JAR human placental JAR cells was measured with a 30 min incubation in the presence of 
choriocarcinoma cells. Transport of carnitine (5 nM) in confluent mono- Na +. When present, the concentration of unlabeled substrate analogs was 
layers of JAR cells was measured at pH 7.5 in the presence of either 500 IxM. Values are means+S.E. Values in parentheses are percent of 
NaCl (O)  or KC1 (O). respective control transport. ND, not determined. 
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300 analysis represented 2.5% of total transport at 2.5 p~M 
carnitine and 14% of total transport at 75 IxM carnitine. 
E25o 
..., o 
03 
o 3.5. Influence o fNa  + on carnitine transport 
~2oo 
e.. e.~ 
.E Since the transport of carnitine in JAR cells exhibits an 
¢P 150 
~ obligatory requirement for Na +, the influence of Na ÷ on 
",= the kinetics of camitine transport was investigated. In these 
• ~ °-10 0 
~, ~ experiments, the concentration of Na + in the transport 
(3 ~ buffer had to be varied by isoosmotically substituting Na ÷ 
50 
E with a suitable cation. Generally, choline or N-methyl- 
v/s glucamine is used for this purpose. However, choline is 
i i i 
25 50 75 structurally similar to carnitine. Even though the data in 
Table 2 show that choline at 0.5 mM does not interfere 
[Carnitine] (taM) with carnitine transport, this may not be true at much 
Fig. 2. Saturation kinetics of carnitine transport in JAR cells. Transport of higher concentrations of choline. Therefore, we first tested 
carnitine in confluent monolayers of JAR cells was measured in the the effect of choline and N-methylglucamine on Na+-de - 
presence of NaC1 with a 30 min incubation. Concentration of carnitine pendent camitine transport at high concentrations of these 
was varied over the range of 2.5-75 I~M. Inset: Eadie-Hofstee transfor- 
mation of the data for the saturable component of transport. The value for cations. It was found that choline did interfere with carni- 
the nonsaturable component was determined by fitting the data for total tine transport at high concentrations, the inhibition being 
transport to a transport model describing a single saturable system plus a very  significant (27%) at 40 mM chol ine.  However, N- 
nonsaturable component. The theoretically derived nonsaturable compo- methylglucamine was without effect even at this high 
nent was subtracted from total transport to calculate the saturable compo- concentration. Therefore, we used N-methylglucamine as 
nent. 
the osmotic substituent for Na ÷ to investigate the influ- 
ence of Na + on carnitine transport. Fig. 3 describes the 
markedly by L-carnitine, D-carnitine, and acetyl-oL-carni- dependence of carnitine transport in JAR cells on the 
tine. As would be expected for a competitive process, the concentration of Na ÷ in the extracellular medium. Whether 
extent of inhibition by these compounds was much greater the concentration of carnitine was 10 nM (Fig. 3A) or 10 
at a [3H]carnitine concentration of 3 nM than at 10 ~M. p~M (Fig. 3B), the transport was hyperbolically related to 
6-N-Trimethyllysine, [3-hydroxybutyrate, and "y-amino- Na ÷ concentration. The linearity of the Hill-type plot of 
butyrate, on the other hand, did not have any effect on the data (Fig. 3, insets) shows that the Na+/carnitine 
carnitine transport. Betaine however caused a significant coupling ratio is 1 at both concentrations of carnitine. The 
inhibition. These data show that the JAR cell camitine apparent dissociation constant for the interaction of Na ÷ 
transport system interacts with L- and D-carnitine and their with the transport system was 6.8 ___ 0.9 mM at 10 nM 
acyl derivatives. The system also interacts with betaine, carnitine. The value was approximately the same (5.0 ___ 0.3 
though with much lesser affinity than for carnitine, mM) at 10 p~M carnitine. 
The saturation kinetics of carnitine transport were then 
3.4. Saturation kinetics of carnitine transport analyzed at two different Na ÷ concentrations, 5 mM and 
50 mM. In these experiments, transport was measured over 
Transport of carnitine in JAR cells was measured in a carnitine concentration range of 2.5-50 ~xM with the 
JAR cells in the presence of Na ÷ over a concentration [3H]carnitine concentration kept constant at 20 nM. The 
range of 2.5-75 p~M. The data given in Fig. 2 demonstrate nonsaturable component was determined by measuring the 
that the transport system is saturable. The experimental transport of radiolabel from 20 nM [3H]carnitine in the 
values were found to fit best (r  = 0.9997) for the follow- presence of excess amount (1 mM) of unlabeled caruitine. 
ing transport model describing a single saturable transport The value calculated from this experimental approach 
system plus a nonsaturable diffusion component agreed well with the value obtained from the theoretical 
Vma x " S approach described in Fig. 2. The nonsaturable component 
V K t + S + K°  " S was subtracted from the total transport o calculate the 
carrier-mediated component and the data for the carrier- 
where V is the transport rate, S is the substrate concentra- mediated component are given in Fig. 4A. At both concen- 
t ion, K t and Vma x are the Michaelis-Menten constant and trations of Na ÷, the transport was hyperbolically related to 
the maximal transport velocity, respectively, for the sat- carnitine concentration. Eadie-Hofstee transformation of 
urable process, and K D is the coefficient for the nonsat- the data showed that the plots were linear (r  2 > 0.99), 
urable component. This analysis gave a value of 12.3 ___ 0.5 indicating participation of a single saturable process under 
IxM for K t and 264 ___ 3 pmol /mg of protein per 30 min both experimental conditions (Fig. 4B). At 50 mM Na ÷, 
for Vm, x. The diffusional component determined from this the kinetic parameters K t and Vm, x were 20.5 __+ 1.0 ~M 
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15o ponent of the cells was separated from the soluble compo- 
A nent by ultracentrifugation, 91 _ 3% of carnitine was found 
E 125 in the soluble fraction. These data demonstrate that carni- o 
m 20 tine was transported into the intracellular space in intact 
~, 1oo 
,-" , ~s ~ JAR cells. 
> "~ 75 ~ 10 ~ .  3.7. Handling of carnitine in plasma membrane ~'esicles 
O :~ 5 ~" 50 from JAR cells 
E 
~- 2s 50 7s loo 12s 1so To compare with the handling of camitine by placental -6 25 
v brush-border membrane vesicles, plasma membrane vesi- 
, ~ , , , cles were prepared from JAR cells and used to study the 
lo ao 3o 40 so interaction of carnitine in the absence of an intact cell 
[Na ÷] (mM] system. Fig. 5A describes the association of carnitine (25 
12s ___4 nM) with JAR cell plasma membrane vesicles in the 
"E B -~ ~ presence or absence of an inwardly directed Na + gradient. 
o loo With a 1 min incubation, association of carnitine with the 
m 20 membrane vesicles was 10.8 _ + 1.1 fmol /mg of protein in 
~ ,  the absence of a Na + gradient. The value increased 2.5-fold 
" 75 is 
._= ~ to 26.7 4- 1.5 fmol /mg of protein in the presence of a Na + 
> ~ ~ 1o gradient. These results show that the association of carni- 
o.° so tine with JAR cell plasma membrane vesicles is Na+-de - 
a, pendent. Interestingly, the Na+-dependent ature of carni- E 
_~ 2s 2's s'o 7's loo l~s tine interaction with the membrane vesicles was evident 
o 
E v even with 4 h incubation (equilibrium) when no Na + 
o. 
, , , , ~ gradient was expected to exist across the plasma mem- 
10 zo 30 40 50 brane. Under these conditions, the amount of carnitine 
[Na +] (mMI associated with the vesicles was 53.7 + 0.6 fmol /mg of 
Fig. 3. Influence of Na + on carnitine transport in JAR cells. Transport of protein in the absence of Na +. This value increased 4.4-fold 
carnitine at two different concentrations, 10nM (A) and 10 IxM (B), was tO 233.7 ___ 4.6 fmo l /mg of protein in the presence  o f  Na +. 
measured with a 30 rain incubation in the presence of increasing concen- These  findings show that the association of carnitine with 
trations of Na + (as NaC1)in the extracellular medium. Osmolality of the the JAR cell plasma membrane vesicles was due to Na +- 
medium was adjusted by adding appropriate concentrations of N-methyl- 
glucamine chloride. The total concentration of NaCI plus N-methyl- dependent binding to the membrane. This binding is appar- 
glucamine chloride in the medium was 140 raM. The values for Na+-de - ently dependent on Na + per se rather than a t ransmem-  
pendent transport (i.e., transport in the presence of Na + minus transport brane Na + gradient. 
in the absence of Na + ) were used to construct Hill-type plots (insets). To validate this conclusion, the handling of serotonin 
by JAR cell plasma membrane vesicles was studied under 
similar experimental conditions. JAR cells express a Na +- 
and 407 + 13 pmol /mg of protein per 30 min. When the dependent serotonin transport system [12]. Brush-border 
Na + concentration was reduced to 5 mM, the correspond- membrane vesicles from normal placenta are also able to 
ing values were 36.2 _+ 1.7 p,M and 367 _+ 13 pmol /mg of transport serotonin into the intravesicular space in a Na + 
protein per 30 min. Thus, Na + increased the affinity of the gradient-dependent manner [16]. Fig. 5B describes the 
transport process for carnitine and had no influence on the handling of serotonin (25 nM) by JAR cell plasma mere- 
maximal transport velocity, brane vesicles in the presence or absence of an inwardly 
directed Na + gradient. With a 1 rain incubation, the 
3.6. Transport versus binding of carnitine in JAR cells amount of serotonin associated with the membrane vesi- 
cles was 70.6 _+ 3.4 fmol /mg of protein in the absence of 
Brush-border membrane vesicles prepared from normal a Na + gradient. This value increased 9.1-fold to 641.4 + 
placenta bind carnitine in a Na+-dependent manner [7]. 103.9 fmol /mg of protein in the presence of a Na + 
Therefore, it was of interest to determine whether or not gradient. These results show that the association of sero- 
the observed association of carnitine with intact JAR cells tonin with JAR cell plasma membrane vesicles is Na+-de - 
was due to transport into the intracellular space. The pendent. This association was however dependent upon the 
amount of carnitine associated with the cells when the transmembrane Na + gradient rather than Na + per se be- 
cells were incubated with 10 nM carnitine for 1 h in the cause, at equilibrium (4 h incubation) when there was no 
presence of Na + was 374 _+ 23 fmol/dish. When the Na + gradient across the membrane, the amount of sero- 
carnitine-loaded cells were lysed and the membrane corn- tonin associated with the vesicles was comparable in the 
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300 presence and in the absence of Na + (304.0 + 6.8 versus 
" A 
"~ 307.4 + 15.9 fmol/mg of protein). Thus, there was no 
o Na+-dependence for serotonin association with JAR cell 
¢n plasma membrane vesicles at equilibrium. These results 
200 
o. are different from those for carnitine interaction. Further- 
._= more, serotonin association with the membrane vesicles 
"~ exhibited the 'overshoot' (i.e., the amount of serotonin 
~" 100 associated with the vesicles in the presence of Na + was 
much higher with 1 min incubation than with 4 h incuba- E 
--~ tion). These results show that the Na + gradient-dependent O 
E transport of serotonin observed in intact JAR cells could e.i 
, , ~ , ~ be demonstrated in purified JAR cell plasma membrane 
~o 2o 30 4o 50 vesicles. In contrast, even though carnitine was transported 
S, [Carnitine] (pM) into the intracellular space in intact JAR cells in a Na+-de - 
3oo pendent manner, only Na+-dependent binding of carnitine 
B could be demonstrated in purified JAR cell plasma mem- 
brane vesicles. 
200 3.8. Characteristics of carnitine binding to JAR cell plasma 
membrane vesicles 
Fig. 6 describes the saturation kinetics of carnitine 
1oo binding to JAR cell plasma membrane vesicles. Equilib- 
rium binding (4 h incubation) was measured over a carni- 
tine concentration range of 0.25-10 p.M. Nonspecific 
binding was determined from the binding of 25 nM 
' ' ' ' [3H]carnitine in the presence of excess amount (1 mM) 
5 10 15 20 
unlabeled carnitine. This component was subtracted from 
V/S total binding to calculate the specific binding. The specific 
Fig. 4. Influence of Na + on carnitine transport kinetics in JAR cells, binding was saturable and Scatchard analysis of the data 
Transport of carnitine in JAR cells was measured with a 30 rain incuba- indicated the presence of a single binding site. The appar- 
tion in the presence of either 50 mM Na ÷ (0 )  or 5 mM Na ÷ (C)) over a ent dissociation constant (K~) for the interaction of carni- 
carnitine concentration ra ge of 2.5-50 p,M. Osmolality of the transport tine with the binding site was 0.66 + 0.08 IxM and the 
buffer was maintained by appropriate addition of N-methylglucamine 
chloride. The total concentration f NaC1 plus N-methylglucamine chlo- maximal binding capacity (nma x) was  174 + 9 pmol/mg 
ride in the buffer was 140 mM. of  protein. 
250 800 
A "E 
~., O 
o a00  L- 
o. ¢~ 600 
E 
E "~- 
~_ o 
o 150 t= 
~ 400 i- 
0 
100  ~ ~ _  
. -  
1 
.10 i,_ 
c .E 200 
-~-- 50 
F 
1 min 4 h 1 rain 4 h 
Fig. 5. Influence of  Na + on the association of  carnitine (A) and serotonin (B) with plasma membrane vesicles from JAR cells. Membrane vesicles were 
preloaded with l0 rnM Hepes/Tris buffer (pH 7.5) containing 75 mM potassium gluconate and 150 mM mannitol. Association of  carnitine (25 nM) or 
serotonin (25 nM) was initiated by mixing 40 Ixl of  membrane suspension (200 p,g membrane protein) with 160 Ixl of  I0 mM Hepes/Tris buffer (pH 7.5), 
containing respective radiolabeled substrate and either 150 mM NaCI (closed bars) or 150 mM KC1 (open bars). The mixture was incubated for either 1 
min or 4 h and the amount of  carnitine or serotonin that was associated with the vesicles was determined by rapid filtration assay. 
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8 contrast, 6-N-trimethyllysine was a weak inhibitor while 
choline was almost totally inactive. 
o o 4. D iscuss ion  
® 4 ~, ~' ~ ° The current investigation was undertaken to character- 
"E ~-- ize the transport of camitine in intact choriocarcinoma 
=o cells of human placental origin and compare the transport 
C) ta. 2 
~ , ~ 8 process with the handling of carnitine by plasma mem- 
a/L brane vesicles isolated from the cells. The results of the 
~ , , r investigation show that the JAR choriocarcinoma cells are 
2 4 8 8 10 able to transport camitine into the intracellular space in a 
[Carnitine] (laM) Na+-dependent manner. There is no involvement of anions 
in the process. Na + stimulates camitine transport by in- 
Fig. 6. Saturation kinetics of carnitine binding in JAR cell plasma creasing the affinity of the transport system for carnitine. 
membrane v sicles. Equilibrium binding of carnitine to membrane prepa- The system is specific for camitine and its acyl derivatives. 
rations was measured in the presence of Na + and with a 4 b incubation. 
Concentration of carnitine was varied over the range of 0.25-10 IzM, but Interestingly, plasma membrane vesicles isolated from 
the concentration of radiolabeled camitine was kept constant at 25 nM. these cells also exhibit Na+-dependent binding, a process 
Nonspecific binding was determined from the amount of radiolabeled which is dependent on Na + rather than a transmembrane 
carnitine bound to the membranes in the presence of excess amount (1 Na  + gradient. Under identical conditions, the membrane 
mM) of unlabeled camitine. This component was subtracted from total vesicles are able to transport serotonin into the intravesicu- 
binding to calculate the saturable specific binding. Inset: Scatchard plot of 
the data. B, carnitine binding in pmol /mg of protein; L, carnitine lar space in response to a Na + gradient, ruling out experi- 
concentration i IzM. Since the amount of carnitine bound to the mem- mental artifacts in the assay procedure. At equilibrium 
brane was < 1% of carnitine present during the binding assay, Scatchard when experimentally imposed ion gradients are expected 
analysis was done using the total carnitine concentration rather than the tO dissipate completely, accumulation of serotonin in the 
free carnitine concentration, vesicles shows no Na+-dependence. In contrast, associa- 
tion of carnitine with the vesicles is clearly Na+-dependent 
under these conditions, indicating that carnitine binds to 
the membranes. The binding process is saturable and is The substrate specificity of the binding process was 
analyzed by determining the ability of various structurally specific for carnitine and its acyl derivatives. 
related unlabeled compounds (100 IxM) to compete with Comparison of carnitine transport in intact JAR cells 
25 nM [3H]carnitine for binding to the JAR cell plasma and carnitine binding in isolated JAR cell plasma mem- 
membrane vesicles (Table 3). L-Carnitine, D-carnitine, and branes reveals similarities between the two processes in 
acetyl-oL-camitine almost totally blocked the binding of important aspects. Both processes are Na+-dependent and 
the substrate specificity of the processes is similar. The [3H]carnitine. Betaine also was a very potent inhibitor. In 
transport process as well as the binding process specifi- 
cally interact with carnitine and its acyl derivatives but not 
with [3-hydroxybutyrate, ~/-aminobutyrate, choline, and 6- 
Table 3 N-trimethyllysine. Betaine also interacts with the transport 
Substrate specificity of the carnitine binding site in JAR cell plasma process as well as the binding process. These two pro- 
membrane vesicles cesses however differ significantly in their affinity for 
Substrate analog [3HlCarnitine transport carnitine. The apparent dissociation constant  (K  t) for car- 
( fmol /mg per 10 min) (%) nitine transport in JAR cells is 12.3 + 0.5 txM while the 
None 118.7 +6.4 100 corresponding value (Ka) for carnitine binding in plasma 
L-Carnitine 5.8_+0.2 5 membranes i 0.7 +_ 0.1 I~M. There are at least three likely 
D-Carnitine 2.7--+0.5 2 explanations for these findings. It is possible that the 
Acetyl-DL-camitine 1.1 -+0.5 1 Na+-dependent carnitine binding and the Na+-dependent 
Betaine 22.0-+ 1.0 18 camitine transport are mediated by two different proteins 
6-N-Trimethyllysine 87.9 _+ 1.9 74 
Choline 111.3_+ 1.1 94 which have different affinities for carnitine. The similari- 
ties in substrate specificity between the two processes may 
Equilibrium binding (4 h incubation) of 25 nM [3H]carnitine to JAR cell indicate a functional relationship, but such as relationship 
plasma membrane preparations was assayed in the absence or in the is yet to be established. Alternatively, the binding observed 
presence of indicated unlabeled substrate analogs (100 ~M). Nonspecific in isolated plasma membrane vesicles is a functional corn-  
binding was determined in the presence of 1 mM unlabeled carnitine and 
this component was subtracted from the total binding to obtain specific ponent of the transporter itself. In intact cells, the t rans-  
binding. Values are means -+ S.E. porter binds carnitine and mediates its transfer across the 
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plasma membrane. In contrast, in isolated plasma mem- tion of carnitine transport via the camitine transporter. The 
brane vesicles the transporter binds camitine but fails to JAR cells may not possess this independent mechanism for 
translocate it across the membrane or the transporter medi- betaine entry across the plasma membrane. Camitine trans- 
ates the transfer of camitine following binding but fails to port in NB-2a cells has been shown to be partially Na+-de - 
release it into the intravesicular space. This might happen pendent [20]. The transport process does not interact with 
if some cellular component is required for the completion choline or ~/-aminobutyrate as has been found in the 
of the transfer process. Such a component is present in present study with JAR cells. 
intact cells but may be lost during preparation of plasma In conclusion, the present study describes the character- 
membrane vesicles. For example, transmembrane transfer istics of carnitine transport in the human placental chorio- 
of carnitine via the transporter may be functionally cou- carcinoma cell line JAR. The transport is active, Na ÷ 
pled to acylation of carnitine which requires acyl-CoA and gradient-dependent, and is specific for carnitine and its 
camitine acyltransferase. It has indeed been documented close structural analogs. We speculate that this transport 
that purified placental brush-border membrane vesicles system may possibly be related to the camitine binding 
possess camitine acyltransferase activity [17]. However, process observed in JAR plasma membrane vesicles. The 
since purified plasma membrane vesicles are devoid of characteristics of carnitine binding to JAR cell plasma 
acyl-CoA, acylation of camitine cannot occur which might membranes are similar to those of carnitine binding to 
interfere with the release of camitine from the transporter, brush-border membranes prepared from normal placenta 
If this is the case, the observed ifference between the K t [7]. It is possible that the carnitine binding observed in 
and the K d values requires explanation. It is possible that placental brush-border membranes i related to the trans- 
the different experimental conditions employed for the port of carnitine from maternal blood into the syncytiotro- 
determination of these two parameters contributed to the phoblast. 
difference in these two values. The K t value is determined 
from the measurements of initial transport rates in the 
presence of a transmembrane Na + gradient over a concen- Acknowledgements 
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